Dec 07 2023 Newsletter – Continuing development of brain tumor therapy Hamlet Biopharma | Newsletter The brain and spinal cord form the central nervous system, where vital functions are controlled. Brain tumors that disturb those functions may be... Read more
Oct 16 2023 Newsletter – Strong anti-tumor effects detected in Alpha1H patients Hamlet Biopharma | Newsletter ... Read more
Pressrelease – Lund, 5 Augusti, 2026 – Hamlet BioPharma tillförs preliminärt cirka 25,7 MSEK genom nyttjande av teckningsoptioner av serie TO5B August 5, 2026
Press Release – Lund, July 28th, 2026 – Grant and impending grant of new patents in the US and Japan July 28, 2026
Pressrelease – Lund, 17 Juli, 2026 – Uppdatering inför ordinarie teckningsperiod för teckningsoptioner TO5B July 17, 2026
